Figure 1. Overall survival time estimated with the Kaplan-Meier method according to the severity of anemia during concurrent chemoradiotherapy. The median survival time was significantly longer in patients with grade 0-2 anemia during chemoradiotherapy (28 months) than in patients with grade 3-4 anemia (20 months; p=0.016).
